Evidence map›Paper›PMID 28549094›Full record

ArticleInvestigative ophthalmology & visual science2017

A Novel Dominant Mutation in SAG, the Arrestin-1 Gene, Is a Common Cause of Retinitis Pigmentosa in Hispanic Families in the Southwestern United States.

Lori S Sullivan, Sara J Bowne, Daniel C Koboldt, Elizabeth L Cadena, John R Heckenlively, Kari E Branham, Dianna H Wheaton, Kaylie D Jones, Richard S Ruiz, Mark E Pennesi and 9 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. History of Finding Genes and Mutations Causing Inherited Retinal Diseases.Cold Spring Harbor perspectives in medicine · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Genetic dissection of non-syndromic retinitis pigmentosa.Indian journal of ophthalmology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Targeting arrestin interactions with its partners for therapeutic purposes.Advances in protein chemistry and structural biology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Lori S SullivanHuman Genetics Center, School of Public Health, The University of Texas Health Science Center, Houston, Texas, United States.
Sara J BowneHuman Genetics Center, School of Public Health, The University of Texas Health Science Center, Houston, Texas, United States.
Daniel C KoboldtNationwide Children's Hospital, Columbus, Ohio, United States.
Elizabeth L CadenaHuman Genetics Center, School of Public Health, The University of Texas Health Science Center, Houston, Texas, United States.
John R HeckenlivelyKellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
Kari E BranhamKellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States.
Dianna H WheatonRetina Foundation of the Southwest, Dallas, Texas, United States.
Kaylie D JonesRetina Foundation of the Southwest, Dallas, Texas, United States.
Richard S RuizRuiz Department of Ophthalmology and Visual Science, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas, United States.
Mark E PennesiCasey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States.
Paul YangCasey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States.
David Davis-BoozerCasey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States.
Hope NorthrupDepartment of Pediatrics, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas, United States.
Vsevold V GurevichVanderbilt University, Nashville, Tennessee, United States.
Rui ChenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Mingchu XuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Yumei LiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
David G BirchRetina Foundation of the Southwest, Dallas, Texas, United States.
Stephen P DaigerHuman Genetics Center, School of Public Health, The University of Texas Health Science Center, Houston, Texas, United States 5Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas, United States.
The University of Texas Health Science Center at Houston · USBaylor College of Medicine · USOregon Health & Science University · USRetina Foundation of the Southwest · USNationwide Children's Hospital · USUniversity of Michigan–Ann Arbor · USVanderbilt University · USW.K. Kellogg Foundation · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
STRUCTURE/FUNCTION STUDIES OF VISUAL ARRESTINR01EY011500 · NEI · VANDERBILT UNIVERSITY · PI T M Iverson · 1997 to 2026
$12.3M
MEASURES OF HUMAN RECEPTOR AND POST RECEPTOR ACTIVITYR01EY009076 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BIRCH, DAVID G, HOOD, DONALD C. · 1991 to 2021
$8.3M
DNA LINKAGE STUDIES OF DEGENERATIVE RETINAL DISEASESR01EY007142 · NEI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DAIGER, STEPHEN P · 1989 to 2017
$4.1M
Neuroprotective Mechanisms of Inosine Monophosphate Dehydrogenase Inhibitors in Retinitis PigmentosaK08EY026650 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI YANG, PAUL · 2016 to 2020
$1.1M
NEI NIH HHS K08 EY026650NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY007142NEI NIH HHS R01 EY009076NEI NIH HHS R01 EY011500
6 · The paper itself

Abstract

Purpose: To identify the causes of autosomal dominant retinitis pigmentosa (adRP) in a cohort of families without mutations in known adRP genes and consequently to characterize a novel dominant-acting missense mutation in SAG. Methods: Patients underwent ophthalmologic testing and were screened for mutations using targeted-capture and whole-exome next-generation sequencing. Confirmation and additional screening were done by Sanger sequencing. Haplotypes segregating with the mutation were determined using short tandem repeat and single nucleotide variant polymorphisms. Genealogies were established by interviews of family members. Results: Eight families in a cohort of 300 adRP families, and four additional families, were found to have a novel heterozygous mutation in the SAG gene, c.440G>T; p.Cys147Phe. Patients exhibited symptoms of retinitis pigmentosa and none showed symptoms characteristic of Oguchi disease. All families are of Hispanic descent and most were ascertained in Texas or California. A single haplotype including the SAG mutation was identified in all families. The mutation dramatically alters a conserved amino acid, is extremely rare in global databases, and was not found in 4000+ exomes from Hispanic controls. Molecular modeling based on the crystal structure of bovine arrestin-1 predicts protein misfolding/instability. Conclusions: This is the first dominant-acting mutation identified in SAG, a founder mutation possibly originating in Mexico several centuries ago. The phenotype is clearly adRP and is distinct from the previously reported phenotypes of recessive null mutations, that is, Oguchi disease and recessive RP. The mutation accounts for 3% of the 300 families in the adRP Cohort and 36% of Hispanic families in this cohort.

Indexed as

Genes, DominantMutation, MissenseAdultAgedArrestinDNA Mutational AnalysisExonsFemaleHigh-Throughput Nucleotide SequencingHispanic or LatinoHumansMaleMiddle AgedPedigreeRetinaRetinitis PigmentosaArrestin

Identifiers

PMID28549094
PMCPMC5455168
OpenAlexW2618394898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.